1 |
中国医师协会呼吸医师分会呼吸病理工作委员会及共识编写专家组. 肺肉芽肿性疾病病理诊断原则及流程专家建议[J]. 中华病理学杂志,2021, 50(7): 719-727.
|
2 |
冯瑞娥. 做好肉芽肿性肺疾病的病理诊断及鉴别诊断[J]. 中华结核和呼吸杂志,2020(12): 1004-1008.
|
3 |
路希维,曾 谊,王凌伟,等. 结核病流行背景下胸内结节病与结核病临床鉴别与处置专家共识[J]. 中国防痨杂志,2022, 44(12): 1227-1241.
|
4 |
Samantha R, Javier R, Radha G, et al. CXCR5+ T helper cells mediate protective immunity against tuberculosis[J]. J Clini Investiga, 2013, 123(2): 712-726.
|
5 |
Bold TD, Ernst JD. CD4+ T cell-dependent IFN-γ production by CD8+ effector T cells in Mycobacterium tuberculosis infection[J]. J Immunol, 2012, 189(5): 2530-2536.
|
6 |
中华医学会呼吸病学分会间质性肺疾病学组,中国医师协会呼吸医师分会间质性肺疾病工作委员会. 中国肺结节病诊治专家共识[J]. 中华结核和呼吸杂志,2019, 42(9): 685-693.
|
7 |
中华医学会,中华医学会杂志社,中华医学会全科医学分会,等. 肺结核基层诊疗指南(2018年)[J]. 中华全科医师杂志,2019, 18(8): 709-717.
|
8 |
Grunewald J, Spagnolo P, Wahlström J, et al. Immunogenetics of Disease-Causing Inflammation in Sarcoidosis[J]. Clin Rev All Immunol, 2015, 49(1): 19-35.
|
9 |
Mannes K, Thomas PS. Sarcoidosis: rarely a single system disorder[J]. Breathe, 2020, 16(4): 200207.
|
10 |
Agrawal R, Kee AR, Ang L, et al. Tuberculosis or sarcoidosis: Opposite ends of the same disease spectrum?[J]. Tuberculosis, 2016, 100(98): 21-26.
|
11 |
Guleria R, Mahashur A, Ghoshal AG, et al. Challenges in diagnosing Sarcoidosis in tuberculosis endemic regions: Clinical scenario in India[J]. Sarcoidosis Vasc Diffuse Lung Dis, 2016, 33(4): 381-384.
|
12 |
Mortaz E, Masjedi MR, Abedini A, et al. Common features of tuberculosis and sarcoidosis[J]. Int J Mycobacteriol, 2016, 1(5): S240-S241.
|
13 |
Thillai M, Atkins CP, Crawshaw A, et al. BTS Clinical Statement on pulmonary sarcoidosis[J]. Thorax, 2021, 76(1): 4-20.
|
14 |
Ma J, Yin H, Hao X, et al. Development of a random forest model to classify sarcoidosis and tuberculosis[J]. Am J Translat Res, 2021, 13(6): 6166-6174.
|
15 |
Jain R, Kumari R, Chakraborty S, et al. T-cell signature cytokines distinguish pulmonary sarcoidosis from pulmonary tuberculosis[J]. Eur J Immunol, 2023, 53(10): e2250255.
|
16 |
Dong Y, Zhou L, Zhang C, et al. Detection of antigen Ag85B expression is useful for the diagnosis of tuberculosis, especially for those with an antituberculosis treatment history[J]. Am J Clin Pathol, 2023, 160(1): 62-71.
|
17 |
Purohit MR, Sviland L, Wiker H, et al. Rapid and specific diagnosis of extrapulmonary tuberculosis by immunostaining of tissues and aspirates with anti-MPT64[J]. Appl Immunohistochem Molecul Morphol, 2017, 25(4): 282-288.
|
18 |
Xue Z, Jia Y, Zhang J. Research progress on CXC chemokines and their receptors in tumor microenvironment[J]. Chin J Cancer Bioth, 2020: 715-724.
|
19 |
胡晓光,陈灿灿,张亚男,等. 机体抗结核分枝杆菌感染的主要免疫细胞及其作用机制[J]. 结核与肺部疾病杂志,2020, 1(1): 71-77.
|
20 |
Gustavsson M. New insights into the structure and function of chemokine receptor: chemokine complexes from an experimental perspective[J]. J Leukocyte Biol, 2020, 107(6): 1115-1122.
|
21 |
Torraca V, Tulotta C, Snaar-Jagalska BE, et al. The chemokine receptor CXCR4 promotes granuloma formation by sustaining a mycobacteria-induced angiogenesis programme[J]. Sci Reports, 2017, 7(1): 45061.
|
22 |
Dorhoi A, Kaufmann SHE. Pathology and immune reactivity: understanding multidimensionality in pulmonary tuberculosis[J]. Sem Immunopathol, 2016, 38: 153-166.
|
23 |
Zhou J, He X, Ou Y, et al. Role of CXCR5+ CD8+ T cells in human hepatitis B virus infection.[J]. Viral Hepat, 2023, 30(8): 638-645.
|
24 |
乔 敏,李姗姗,刘荣梅,等. CC趋化因子和CXC趋化因子及其受体在结核分枝杆菌感染免疫应答中作用的研究进展[J]. 细胞与分子免疫学杂志,2021, 37(4): 373-377.
|
25 |
Lewinsohn DM, Lewinsohn DA. The missing link in correlates of protective tuberculosis immunity: recognizing the infected cell[J]. Front Immunol, 2022, 13: 869057.
|
26 |
吴桂辉,黄 涛,罗 槑,等. 活动性肺结核患者病情严重程度与维生素D及T细胞亚群的相关性分析[J/CD]. 中华肺部疾病杂志(电子版), 2020, 13(4): 510-512.
|
27 |
Ardain A, Domingo-Gonzalez R, Das S, et al. Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis[J]. Nature, 2019, 570(7762): 528-532.
|
28 |
Lu Y J, Barreira-Silva P, Boyce S, et al. CD4 T cell help prevents CD8 T cell exhaustion and promotes control of Mycobacterium tuberculosis infection[J]. Cell Reports, 2021, 36(11): 109696.
|
29 |
Chen ES, Moller DR. Etiologies of sarcoidosis[J]. Clin Rev All Immunol, 2015, 49: 6-18.
|
30 |
Cho HS, Kim SJ, Yoo JY. Sarcoidosis during treatment of pulmonary tuberculosis: a rare case report and review of the literature[J]. J Int Med Res, 2021, 49(4): 3000605211001632.
|
31 |
Gupta D, Agarwal R, Aggarwal AN, et al. Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis[J]. Eur Res J, 2007, 30(3): 508-516.
|
32 |
Yamaguchi T, Costabel U, McDowell A, et al. Immunohistochemical detection of potential microbial antigens in granulomas in the diagnosis of sarcoidosis[J]. J Clin Med, 2021, 10(5): 983.
|
33 |
Fang C, Huang H, Xu Z. Immunological evidence for the role of mycobacteria in sarcoidosis: a meta-analysis[J]. PLoS One, 2016, 11(8): e0154716.
|